Tag Archives: cancer

Sugars – The Key to Talking to Our Cells

We are one step closer to achieving communication with those 37.2 trillion tiny cells making up our bodies. Just last year, researchers at the University of British Columbia, led by Dr. Stephen Withers, found a way to modify the sugars essential to this communication by using chemicals found in bacteria. The same bacteria living in our gut!

WHAT EXACTLY ARE SUGARS?

No ambiguity here! Chemists work with sugars based off molecules in this sugar cube. Credits: The Verge

To be specific, the sugars Withers’ team studied were simple sugars; hexagonal-shaped molecules, often joined to other molecules known as “acceptors”. The problem chemists face is like the average love life. 

Similar to starting a relationship with someone, joining acceptors to sugars is also quite difficult. Luckily for sugars, Mother Nature has come up with some solutions: enzymes, which are helper molecules that speed up the pairing or unlinking of two molecules.

A SOLUTION UNDER OUR NOSES…

Instead of struggling to find ways of joining sugars and acceptors, Withers’ team thought: Why not hijack Mother Nature and use these enzymes? To make their idea a reality, they extracted sugar-specific enzymes from E. Coli, a type of bacteria that lives inside the human gut.

These bacteria manufactured 175 sugar-specific enzymes, and from these they chose eight enzymes that were compatible with the sugars and acceptors they were interested in.

It seemed like Withers’ team now had everything needed to join the desired acceptors to the sugars; however, there was still a problem. The sugar-specific enzymes they got from E. Coli did the exact opposite of what they wanted; instead of forming sugar-acceptor linkages, they specialized in breaking them.

Enzymes that break sugar-acceptor linkages are analogous to using a screwdriver to loosen a screw, while enzymes that form sugar-acceptor linkages are like tightening a screw.

A small modification changes the function of the enzyme. Credits: Blog post authors

To solve this problem, they reverse-engineered the enzymes specialized in breaking linkages into those that form linkages, by changing a small part of the enzymes’ structure, similar to changing the tips on a screwdriver. As a result, Withers’ team now had eight enzymes specialized in forming different sugar-acceptor linkages. 

MORE THAN JUST A BOND…

Now being able to freely and efficiently modify sugars, there is a big potential for researchers to join in on the conversations with our cells. Why is this important? Often, there is miscommunication within our cells which can lead to serious trouble. 

One example is cancer; which is partly caused by cancer cells using abnormal sugar molecules as a form of miscommunication, to avoid being cleared up by immune cells. One potential treatment is a sugar-based vaccine, which allows our immune cells to more efficiently target tumor cells.

The challenge of creating a sugar-based vaccine isn’t just relevant to cancer, but other diseases as well which also occur  as a result of miscommunication. With Withers’ research, designing these sugar-based drugs won’t be as difficult thanks to their novel way of bonding sugars to other molecules. This research brings us one step closer to talking to our cells, helping with the battle against diseases.

Story source

Armstrong, Z.; Liu, F.; Chen, H.-M.; Hallam, S. J.; Withers, S. G. Systematic Screening of Synthetic Gene-Encoded Enzymes for Synthesis of Modified Glycosides. ACS Catalysis 20199 (4), 3219–3227.

– Kenny Lin, Pricia Ouyang, Tom Hou, Aron Engelhard (CO-10)

Revised: Targeting Oxygen sensitive Hypoxia-inducible factors (HIF-1s) can help cure cancer

The 2019 medicine Nobel Prize winner Dr. Gregg L. Semenza found out that targeting the oxygen-regulated hypoxia-inducible factors (HIF-1s) in the cells can help cure cancers.

What are HIF-1s?

We all need oxygen to be alive. In our body, only red blood cells that contain hemoglobin can deliver oxygen for all the other cells. During a shortage of oxygen, erythropoietin (EPO) increases the production of red blood cells. Hence, more red blood cells are available to bind and deliver oxygen from the lung to the other parts of the body.

Besides, vascular endothelial growth factors (VEGFs) can stimulate the formation of blood vessels in response to the lack of oxygen. By forming more blood vessels, the body can ensure that oxygen can get to other cells in different parts of the body.

Red blood cells transport. Source: HealthLink Canada

 

HIFs are the oxygen sensing knob in our bodies. Hypoxia-inducible factors (HIF-1s) are composed of two different subunits-one being an oxygen-regulated HIF alpha subunit and the other being an oxygen insensitive HIF beta subunit.

The alpha subunit of the HIFs can sense the oxygen concentration changes. When the oxygen level is low, the two HIF subunits join to assemble the dimeric HIF-1s. The HIF-1s can then bind to genes that express EPOs and VEGFs. As a result, more EPOs and VEGFs are available to deliver limited oxygen to cells in different parts of the body. Meanwhile, when the oxygen level is high, fewer HIF subunits form the dimeric HIF-1s. Thus, fewer HIF-1s can bind to EPOs and VEGFs genes, which further leads to less EPOs and VEGFs proteins being expressed.

How can the researchers target HIF-1s to cure cancers?
YouTube Preview Image

Nobel Prize Winner, Gregg Semenza on the discovery of HIF-1. Source: Johns Hopkins Medicine

Cancer is a group of diseases with abnormal cell growth. Many studies have shown that tumor metastasis strongly correlates to the elevated levels of HIF-1s. Unlike normal cells, cancer cells have adaptive responses to hypoxic stress, meaning that they can survive and divide under low oxygen levels.

Therefore, HIF-1s can be targeted to treat cancer. By inhibiting the dimeric HIF-1s, cancer cells will have fewer EPOs and VEGFs. Without the adaptive response to low oxygen level, cancer cells will die. The HIF-1s inhibitors can combine with other anti-cancer drugs to kill off cancer cells.

The discovery of this oxygen-sensitive knob HIF-1s is a milestone in cancer treatments. Cancers perhaps are not that scary.

Journal Reference:

Gregg L. Semenza. Pharmacological targeting of hypoxia-inducible factors. Annual Review of Pharmacology and Toxicology, 2019; 59: 379-403 DOI: https://doi.org/10.1146/annurev-pharmtox-010818-021637

Georgina N. Masoud and Wei Li. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sinica B, 2015; 5: 378-389 DOI: https://doi.org/10.1016/j.apsb.2015.05.007

 

-Pricia Ouyang

Feb 15th, 2020

These Ingredients in Sunscreen Might Promote Breast Cancer

Breast cancer is the most diagnosed cancer with an estimated diagnosis of 331,530 women and 2670 men this year in the US alone. Research by the University of Massachusetts Amherst published on January 15 2020 observed that chemicals in everyday items can increase the chances of breast cancer in women.

Cancer is a dangerous illness, caused by the uncontrolled division of cells in the body. It is predicted that this year 41,760 women and 500 men will die of breast cancer in the US.  These estimations may now have to take into consideration th

Chemical Structure of Benzophenone-3 aka Oxybenzone Source: Wikipedia

e dangers of sunscreen and cosmetics, including makeup, hair products, and moisturizers.These everyday products are known to contain the chemicals benzophenone-3 (BP-3) and propylparaben (PP).

The study indicates that previous research into the effects of BP-3 had shown that only extremely high concentrations could promote cancer growth. Since these concentrations were far beyond the n

Chemical Structure of Propylparaben Source: Wikipedia

ormal levels of exposure to women, there was no cause for concern.

However, the study showed that mice exposed to oils containing BP-3 and PP had an increase in cancer. The results suggest that BP-3 and PP effect cells that contain oestrogen receptors. High levels of oestrogen has previously been linked to an increase in breast cancer.  The exposure to BP-3 and PP at only a fraction of the cancer promoting concentration was shown to increase DNA damage by causing structures known as R-Loops.

Dr Joesph Jerry of UMass Amherst, science director of Pioneer Valley Institute, and co-director of Rays of Hope Centre for Breast Cancer. Source: UMass Amherst from EurekAlert!

Based on the results, Dr Joseph Jerry, the professor of Veterinary & Animal Sciences at the University of Massachusetts Amherst warns that, “There may be a risk at lower levels than we would have previously understood,”.

The study shows that DNA damage only occurs in cells containing oestrogen receptors, and that all other cells show no adverse effects.

It might be time to take a look at the ingredients in your everyday items!

– Chantell Jansz

Targeting Oxygen sensitive Hypoxia-inducible factors (HIF-1s) can help cure Anemia and Cancers

The 2019 medicine Nobel Prize winner Dr. Gregg L. Semenza found out that cancers and Anemia can be cured by targeting the oxygen-regulated hypoxia-inducible factors (HIF-1s) in the cells.

What are HIF-1s and how are they related to oxygen? 

We all need Oxygen to be alive. At a cellular level, oxygen is essential to cell viability as it provides an energy source (ATP) for important cellular activities. In our body, only red blood cells that contain hemoglobin can deliver oxygen for all the other cells. During a shortage of oxygen, erythropoietin (EPO) increases the production of red blood cells. Hence, more red blood cells are available to bind and deliver oxygen from the lung to the other parts of the body. Besides, vascular endothelial growth factors (VEGFs) can stimulate the formation of blood vessels in response to the lack of oxygen. By forming more blood vessels, the body can ensure that oxygen can get to other cells in different parts of the body.

HIFs are the oxygen sensing knob in our bodies. Hypoxia-inducible factors (HIF-1s) are composed of two different subunits-one being an oxygen-regulated HIF alpha subunit and the other being an oxygen insensitive HIF beta subunit.

The alpha subunit of the HIFs can sense the oxygen concentration changes. When the oxygen level is low, the two HIF subunits join to assemble the dimeric HIF-1s. The HIF-1s can then bind to genes that express EPOs and VEGFs. As a result, more EPOs and VEGFs are available to deliver limited oxygen to cells in different parts of the body. Meanwhile, when the oxygen level is high, fewer HIF subunits form the dimeric HIF-1s. Thus, fewer HIF-1s can bind to EPOs and VEGFs genes, which further leads to less EPOs and VEGFs proteins being expressed.

How can the researchers target the HIF-1s to cure cancer and Anemia?

YouTube Preview Image

Cancer is a group of diseases with abnormal cell growth. HIF-1s can be targeted to treat cancer because by inhibiting the dimeric HIF-1s, the cancer cells will have fewer EPOs and VEGFs. Therefore, the cancer cells will have much harder time oxygen and without enough oxygen, these cancer cells can die.

 “By adding a small molecule that inhibits HIF-1s, added on to the other cancer drugs that patients are receiving, will allow those other drugs to be more effective in fighting cancer,’ said Dr. Semenza

“And as for Anemia, targeting the HIF-1s could show promising effect.”

 He added: “Anemia is associated with the lower-than-normal amount of red blood cells or hemoglobin. By taking a pill of a drug that increases HIF-1s activity and turns on EPO.”

The discovery of this oxygen-sensitive knob HIF-1s is a milestone in cancer and Anemia treatments. Cancers and Anemia perhaps are not that scary.

 

Journal Reference :

Gregg L. Semenza. Pharmacological targeting of hypoxia-inducible factors. Annual Review of Pharmacology and Toxicology, 2019; 59: 379-403 DOI: https://doi.org/10.1146/annurev-pharmtox-010818-021637

-Pricia Ouyang

Jan 27th, 2020

These Ingredients in Sunscreen Might Promote Breast Cancer

Breast cancer is the most diagnosed cancer with an estimated diagnosis of 331,530 women and 2670 men this year in the US alone. Cancer is a incredibly dangerous illness, caused by the unfiltered division of cells in the body. It is predicted that this year 41,760 women and 500 men will die of breast cancer in the US. Research by the University of Massachusetts Amherst published on January 15 2020 found that benzophenone-3 (BP-3) and propylparaben (PP) can increase the chances of breast cancer.

Because of this, the estimations may now have to take into consideration the dangers of common everyday items that include the chemicals BP-3 and PP. BP-3 is commonly found in sunscreen as it helps to block harmful UV light that may cause damage to the skin. PP is a chemical widely used in the cosmetics industry and can be found in items such as makeup, hair products and moisturisers.

Previous research into the effects of BP-3 had shown that only extremely high concentrations could promote cancer growth. Since these concentrations were far beyond the normal levels of exposure to women, there was no cause for concern. However, this new research shows that cells containing oestrogen receptors, important for regulating gene activity, require only a fraction of the cancer promoting concentration of BP-3 to cause damage to the DNA of the cell. “There may be a risk at lower levels than we would have previously understood,” says professor of Veterinary & animal Sciences at the University of Massachusetts Amherst, science director of Pioneer Valley Institute, and co-director of Rays of Hope Centre for Breast Cancer Research, Dr. Joseph Jerry.

The study shows that DNA damage only occurs in cells containing oestrogen receptors, and that all other cells show no adverse effects.

It might be time to take a look at the ingredients in your everyday items!

 

– Chantell Jansz